New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
September 5, 2012
05:55 EDTARDM, ARDM, SNTA, SNTA, RNN, RNN, FVE, FVE, VICL, VICL, EXEL, EXEL, ENDP, ENDP, CNDO, CNDO, VASC, VASC, ENSG, ENSG, BIIB, BIIB, BDSI, BDSI, VOLC, VOLCStifel Nicolaus to host a conference
Healthcare Conference 2012 is being held in Boston on September 5-6.
News For ARDM;BDSI;BIIB;ENSG;VASC;CNDO;ENDP;EXEL;VICL;FVE;RNN;SNTA;VOLC From The Last 14 Days
Check below for free stories on ARDM;BDSI;BIIB;ENSG;VASC;CNDO;ENDP;EXEL;VICL;FVE;RNN;SNTA;VOLC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
May 24, 2013
07:20 EDTBIIBCelgene, Gilead, and Biogen could go much higher, says Bernstein
Subscribe for More Information
May 23, 2013
08:04 EDTBIIBBiogen appoints Spyros Artavanis-Tsakonas as Chief Scientific Officer
Subscribe for More Information
05:48 EDTVOLCVolcano announces preliminary results from ADVISE II study
Subscribe for More Information
May 22, 2013
10:00 EDTVOLCOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:31 EDTVOLCVolcano upgraded to Overweight from Equal Weight at First Analysis
Subscribe for More Information
May 21, 2013
07:24 EDTBIIBGlobal Health Care to host a conference
Subscribe for More Information
05:44 EDTBIIBBiogen submits application to FDA for approval of Plegridy in RMS
Subscribe for More Information
May 20, 2013
15:57 EDTBIIBBiogen IMS numbers should not be adjusted down at ISI Group
ISI Group confirmed with Biogen that Tecfidera is not captured by IMS and numbers should not be adjusted downward to reflect free drugs dispensed.
15:55 EDTVOLCVolcano added to Best Ideas List at Barrington
Subscribe for More Information
07:39 EDTBIIBBiogen weekly MS drug scripts up 26.5%, says Citigroup
Citigroup says weekly scripts for Biogen's multiple sclerosis drug Tecfidera were up 26.5% to 1,621. Citi says the launch of Tecfidera is on track to beat Q2 estimates by a wide margin and it keeps a Buy rating on shares of Biogen.
May 17, 2013
11:53 EDTENDPOptions with decreasing implied volatility: SGMO ARNA CSC ENDP
Subscribe for More Information
May 16, 2013
16:13 EDTVASCVascular Solutions files patent infringement complaint against Boston Scientific
Vascular Solutions (VASC) announced that it has filed a patent infringement complaint in the U.S. District Court for the District of Minnesota against Boston Scientific Corporation (BSX). The complaint alleges that Boston Scientific has infringed three patents owned by Vascular Solutions concerning rapid exchange guide extension technology by manufacturing and selling its Guidezilla guide extension catheter which received 510(k) clearance in March. Vascular Solutions is seeking an injunction against Boston Scientific prohibiting the manufacture and sale of its Guidezilla catheter as well as damages for lost profits and legal costs.
10:03 EDTENDPOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:27 EDTENDPEndo Health upgraded to Buy from Neutral at Buckingham
Buckingham upgraded Endo Health based on attractive risk/reward and expectations for a more detailed strategy from the new CEO, maybe by Q2 results. Price target remains $41.
07:29 EDTBIIBLeerink to host a bus tour
Boston Biopharma Bus Tour travels throughout Boston on May 16-17.
May 14, 2013
15:09 EDTBIIBBiogen has a conference call hosted by JPMorgan
JPMorgan Analysts Meacham and Kasimov host a conference call with CEO George Scangos and CFO Paul Clancy on May 17 at 10 am.
07:18 EDTEXELBofA/Merrill to host a conference
2013 Health Care Conference is being held in Las Vegas on May 14-16.
May 13, 2013
11:12 EDTBIIBBiogen MS drug scripts grew 38% week-over-week, says Leerink
Subscribe for More Information
09:27 EDTENDPEndo Health downgraded to Market Perform from Outperform at William Blair
09:25 EDTENDPOn The Fly: Pre-market Movers
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.